Electrophoretic mobility shift assay analysis of NFκB transcriptional regulation by nuclear IκBα

Methods in Molecular Biology

Volumn 809, Issue , 2012, Pages 49-62

  Juvekar, Ashish ^a   Ramaswami, Sitharam ^a   Manna, Subrata ^a   Chang, Tzu Pei ^a   Zubair, Adeel ^a   Vancurova, Ivana ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Electrophoretic mobility shift assay; MG132; NF B; Nuclear I B ; Nuclear translocation; Proteasome inhibition; si RNA; Transcriptional regulation

Indexed keywords

ATP DEPENDENT 26S PROTEASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROTEASOME;

ARTICLE; CELL LINE; GEL MOBILITY SHIFT ASSAY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 84555187914     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-376-9_3     Document Type: Article

References (24)

1. Baeuerle, P, A. and Baltimore, D. (1996) NF-B: ten years after. Cell 87, 13-20.
2. Ghosh, S. and Karin, M. (2002) Missing pieces in the NF-B puzzle. Cell 109, S81-96.
3. Barnes, P. J. and Karin, M. (1997) NF-B-a pivotal transcription factor in chronic infl ammatory diseases. New Engl. J. Med. 336, 1066-1071. (Pubitemid 27163860)
4. Baldwin, A. S. (2001) The transcription factor NF-B and human disease. J. Clin. Invest. 107, 3-6. (Pubitemid 32047404)
5. Yamamoto, Y. and Gaynor, R. B. (2001) Therapeutic potential of inhibition of the NF-B pathway in the treatment of infl ammation and cancer. J. Clin Invest. 107, 135-142. (Pubitemid 32096826)
6. Hayden, M. S. and Ghosh, S. (2008) Shared principles in NF-B signaling. Cell 132, 344-362.
7. Prasad, S., Ravindran, J. and Aggarwal, B. B. (2010) NF-B and cancer: how intimate is this relationship. Mol. Cell. Biochem. 336, 25-37.
8. Bharti, A. C. and Aggarwal, B. B. (2002) NF-B and cancer: its role in prevention and therapy. Biochem. Pharmacol. 64, 883-888. (Pubitemid 35238030)
9. Dutta, J., Fan, Y., Gupta, N., Fan, G. and Gelinas, C. (2006) Current insights into the regulation of programmed cell death by NF-B. Oncogene 25, 6800-6816. (Pubitemid 44657853)
10. Karin, M. (2006) NF-B in cancer development and progression. Nature 441, 431-436.
11. Wan, F. and Lenardo, M. J. (2010) The nuclear signaling of NF-B: current knowledge, new insights, and future perspectives. Cell. Res. 20, 24-33.
12. Lenz, G. and Staudt, L. M. (2010) Aggressive lymphomas. N. Engl. J. Med. 362, 1417-1429.
13. Mancino, A. and Lawrence, T. (2010) NF-B and tumor-associated macrophages. Clin. Cancer Res. 16, 784-789.
14. Karin, M. and Neriah, Y. B. (2000) Phosphorylation meets ubiquitination: The control of NF- B activity. Annu. Rev. Immunol. 18, 621-663. (Pubitemid 30365393)
15. McConkey, D.J. and Zhu, K. (2008) Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist. Updat. 11, 164-179.
16. Shah, J. J. and Orlowski, R. Z. (2009) Proteasome inhibitors in the treatment of multiple myeloma. Leukemia 23, 1964-1979.
17. Izban, K. F., Ergin, M., Qin, J. Z., Martinez, R. L., Pooley, R. J., Saeed, S. and Alkan, S. (2000) Constitutive expression of NF-B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis. Hum. Pathol. 31, 1482-1490. (Pubitemid 32047000)
18. Sors, A., Jean-Louis, F., Pellet, C., Laroche, L., Dubertret, L., Courtois, G., Bachelez, H. and Michel, L. (2006) Down-regulating constitutive activation of the NF-B canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Blood 107, 2354-2363. (Pubitemid 43345555)
19. Sors, A., Jean-Louis, F., Bégué, E., Parmentier, L., Dubertret, L., Dreano, M., Courtois, G., Bachelez, H. and Michel, L. (2008) Inhibition of I B kinase subunit 2 in cutaneous T-cell lymphoma down-regulates NF-B constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents. Clin. Cancer Res. 14, 901-911. (Pubitemid 351231175)
20. Kiessling, M. K., Klemke, C. D., Kaminski, M. M., Galani, I. E., Krammer, P. H. and Gulow, K. (2009) Inhibition of constitutively activated NF-B induces reactive oxygen species and irondependent cell death in cutaneous T-cell lymphoma. Cancer Res. 69, 2365-2374.
21. Vu, H.Y., Juvekar, A., Ghosh, C., Ramaswami S., Le, D. H. and Vancurova, I. (2008) Proteasome inhibitors induce apoptosis of prostate cancer cells by inducing nuclear translocation of Arch. Biochem. Biophys. 475, 156-163.
22. Castro-Alcaraz, S., Miskolci, V., Kalasapudi, B., Davidson, D. and Vancurova, I. (2002) NF-B regulation in human neutrophils by nuclear I B : correlation to apoptosis. J. Immunol. 169, 3947-3953.
23. Ghosh, C. C., Ramaswami, S., Juvekar, A., Vu, H. Y., Galdieri, L., Davidson, D. and Vancurova, I. (2010) Gene specifi c repression of proinfl ammatory cytokines in stimulated human macrophages by nuclear I B J. Immunol. 185, 3685-3693.
24. Vancurova, I., Miskolci, V. and Davidson, D. (2001) NF-B activation in TNF -stimulated neutrophils is mediated by protein kinase C Correlation to nuclear I B J. Biol. Chem. 276, 19746-19752.